No positive effect of rhdnase on the pulmonary colonization in children with cystic fibrosis

No positive effect of rhdnase on the pulmonary colonization in children with cystic fibrosis

Background. Long-term clinical trials have shown that daily treatment with recombinant human deoxyribonuclease (rhDNAse) in patients with mild to moderate cystic fibrosis (CF) improves lung function and decreases the number of respiratory exacerbations. The aim of this study was to analyze the effec...

Full description

Bibliographic Details
Main Authors:	H.J.C. Bonestroo, M.G. Slieker, H.G.M. Arets
Format:	Article
Language:	English
Published:	PAGEPress Publications 2016-01-01
Series:	Monaldi Archives for Chest Disease
Subjects:	Cystic Fibrosis rhDNAse Pseudomonas aeruginosa Pulmonary colonization
Online Access:	https://www.monaldi-archives.org/index.php/macd/article/view/308

Similar Items

Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications
by: Wang Chun Kwok, et al.
Published: (2021-04-01)

Evaluation of biofilm production by Pseudomonas Aeruginosa isolates recovered from cystic fibrosis and non-cystic fibrosis patients
by: L.R.R. Perez, et al.
Published: (2011-06-01)

Antibiotic Susceptibility of Pseudomonas Aeruginosa Isolated from Cystic Fibrosis Patients
by: Soltan Dallal, MM, et al.
Published: (2015-01-01)

Detection of Morphotyping Characteristics Identification Antibiotic Resistance of Pseudomonas aeruginosa Isolated from Patients with Cystic Fibrosis
by: Hossein Fazeli, et al.
Published: (2012-03-01)

THE PREVALENCE OF PSEUDOMONAS AERUGINOSA STRAINS IN INFANTS WITH CYSTIC FIBROSIS WITHIN A HOSPITAL IN NORTH EASTER OF ROMANIA
by: Oana Alexandra Ciocan, et al.
Published: (2016-11-01)

Сlinical observation of the child with cystic fibrosis
by: V.A. Klymenko, et al.
Published: (2017-08-01)

CD14 C-159T and early infection with <it>Pseudomonas aeruginosa </it>in children with cystic fibrosis
by: Sly PD, et al.
Published: (2005-06-01)

Gender-affirming hormone therapy in cystic fibrosis – A case of new Pseudomonas infection
by: L. Shaffer, et al.
Published: (2021-01-01)

No benefit of longer eradication therapy of Pseudomonas aeruginosa primoinfections in pediatric cystic fibrosis
by: F. Claude, et al.
Published: (2019-03-01)

COMPARISON OF EFFICACY AND TOXICITY OF TWO TOBRAMYCIN DOSING REGIMENS IN CYSTIC FIBROSIS.
by: Lund, Mary Ellen.
Published: (1983)

Comparison of the worldwide transmissible Pseudomonas aeruginosa with isolates from brazilian cystic fibrosis patients
by: Robson Souza Leão, et al.
Published: (2010-12-01)

Bacterial Subversion of Autophagy in Cystic Fibrosis
by: Verónica Roxana Flores-Vega, et al.
Published: (2021-10-01)

Phenotypic characterization and PCR-Ribotypic profile of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Iran
by: Hossein Fazeli, et al.
Published: (2013-01-01)

Disruption of Cross-Feeding Inhibits Pathogen Growth in the Sputa of Patients with Cystic Fibrosis
by: Jeffrey M. Flynn, et al.
Published: (2020-04-01)

Catabolism of Nucleic Acids by a Cystic Fibrosis Pseudomonas aeruginosa Isolate: An Adaptive Pathway to Cystic Fibrosis Sputum Environment
by: Sheemal Shanista Kumar, et al.
Published: (2019-05-01)

A Metagenomic approach to characterize temperate bacteriophage populations from cystic fibrosis and non-cystic fibrosis bronchiectasis patients
by: Mohammad Adnan Tariq, et al.
Published: (2015-02-01)

Does NETosis contribute to the bacterial pathoadaptation in Cystic Fibrosis?
by: Samir eRahman, et al.
Published: (2014-08-01)

Competition in Biofilms between Cystic Fibrosis Isolates of Pseudomonas aeruginosa Is Shaped by R-Pyocins
by: Olubukola Oluyombo, et al.
Published: (2019-01-01)

Nutritional modeling of bacterial infections : physiology and metabolism of Pseudomonas aeruginosa during growth in cystic fibrosis sputum
by: Palmer, Kelli Lea, 1981-
Published: (2012)

Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains
by: De Fabritiis, S., et al.
Published: (2022)

Prevalence and antimicrobial susceptibility of respiratory pathogens in patients with cystic fibrosis
by: Vilma Almeida Paixão, et al.

Quantitative Framework for Model Evaluation in Microbiology Research Using Pseudomonas aeruginosa and Cystic Fibrosis Infection as a Test Case
by: Daniel M. Cornforth, et al.
Published: (2020-01-01)

Life in the cystic fibrosis upper respiratory tract influences competitive ability of the opportunistic pathogen Pseudomonas aeruginosa
by: Jeffrey J. Bara, et al.
Published: (2018-01-01)

Correlación clinico-microbiológica en 9 pacientes con fibrosis quística
by: Eloísa Martí Castelló, et al.
Published: (1996-08-01)

Inhaled antibiotics for the treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients: challenges to treatment adherence and strategies to improve outcomes
by: Bodnár R, et al.
Published: (2016-02-01)

State of the Art: Why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?
by: Davis Pamela B, et al.
Published: (2003-08-01)

Liposomal clarithromycin delivery for the treatment of pseudomonal lung infection in cystic fibrosis.
by: Alhajlan, Mai Mohsen A.
Published: (2013)

The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics
by: Atqah AbdulWahab, et al.
Published: (2017-01-01)

Comparison of virulence factors and antibiotic resistance of Pseudomonas aeruginosa strains isolated from patients with and without cystic fibrosis
by: Macin Salih, et al.
Published: (2017-10-01)

Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities
by: Nicole Acosta, et al.
Published: (2020-04-01)

γδ T lymphocytes from cystic fibrosis patients and healthy donors are high TNF-α and IFN-γ-producers in response to <it>Pseudomonas aeruginosa</it>
by: Martínez Natalia, et al.
Published: (2003-09-01)

Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo
by: YongTao Li, et al.
Published: (2017-07-01)

Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum
by: Laura eLine, et al.
Published: (2014-10-01)

Evaluation of type IV pilin sub groups in Pseudomonas aeruginosa isolated from environmental samples, cystic fibrosis and burn patients
by: Alireza Salimi chirani, et al.
Published: (2014-10-01)

Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis
by: Hsieh MH, et al.
Published: (2018-08-01)

Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic Fibrosis Patients
by: Natalia Molchanova, et al.
Published: (2019-02-01)

Tipificación molecular de aislamientos de Pseudomonas aeruginosa obtenidos de pacientes con fibrosis quística Molecular typification of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis
by: N. G. Iglesias, et al.
Published: (2008-03-01)

Interaction between Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
by: Jingming Zhao, et al.
Published: (2018-11-01)

A laminar flow model of aerosol survival of epidemic and non-epidemic strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis
by: Clifton, I.J., et al.
Published: (2008)

Molecular typing and biological characteristics of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Brazil
by: Eliana Guedes Stehling, et al.